Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
US6720330B2 · kind B2 · utility
19Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2001 |
| Grant date | Apr 13, 2004 |
| Priority date | — |
| Expiry date | Sep 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds according to the formula A—Z—W as herein described, wherein A is selected from the groups consisting of: A′—(CH2)n—, A′—(CH2)nSO2—, and A′—(CH2)nCO—, where n is 0 to 4; and A′ is selected from(a) (C6-C10)aryl-, or(b) (C1-C9)heteroaryl-; which groups may be optionally substituted; and pharmaceutically acceptable salts, solvates or hydrates thereof; pharmaceutical compositions thereof; and methods useful to facilitate secretion of growth hormone(GH) in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.